Methods
This registry study includes 681 consecutive patients with AMI as the first manifestation of coronary artery disease (CAD) who received PCI and were discharged on statin. The study outcomes were the rates of in-hospital death, recurrent AMI, length of stay, ejection fraction (EF) and peak troponin levels.
Methods
This registry study includes 681 consecutive patients with AMI as the first manifestation of coronary artery disease (CAD) who received PCI and were discharged on statin. The study outcomes were the rates of in-hospital death, recurrent AMI, length of stay, ejection fraction (EF) and peak troponin levels.